Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 9/1/16 → 1/5/26 |
Funding
- Orbus Therapeutics Incorporated: $67,678.00
A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
- Villano, PhD, John (PI)
- Thind, Ravneet (CoI)